Tissue plasminogen activator: From molecular biology to myocardial infarction

K. R. Chien, R. Meidell, R. Gerard

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The recent development of recombinant tissue plasminogen activator as a therapeutic agent during acute myocardial infarction is one of the most lucid examples of the potential impact of recombinant DNA technology in clinical medicine. This remarkable achievement would not have been possible without several key discoveries in molecular biology and clinical cardiology and exemplifies the synergistic relationship between basic and clinical research. This article chronicles this journey from molecular biology to myocardial infarction.

Original languageEnglish (US)
Pages (from-to)201-207
Number of pages7
JournalAmerican Journal of the Medical Sciences
Volume293
Issue number3
StatePublished - 1987

Fingerprint

Tissue Plasminogen Activator
Molecular Biology
Myocardial Infarction
Recombinant DNA
Clinical Medicine
Cardiology
Technology
Research
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tissue plasminogen activator : From molecular biology to myocardial infarction. / Chien, K. R.; Meidell, R.; Gerard, R.

In: American Journal of the Medical Sciences, Vol. 293, No. 3, 1987, p. 201-207.

Research output: Contribution to journalArticle

Chien, K. R. ; Meidell, R. ; Gerard, R. / Tissue plasminogen activator : From molecular biology to myocardial infarction. In: American Journal of the Medical Sciences. 1987 ; Vol. 293, No. 3. pp. 201-207.
@article{93aa904545294808943cfda9a965a2be,
title = "Tissue plasminogen activator: From molecular biology to myocardial infarction",
abstract = "The recent development of recombinant tissue plasminogen activator as a therapeutic agent during acute myocardial infarction is one of the most lucid examples of the potential impact of recombinant DNA technology in clinical medicine. This remarkable achievement would not have been possible without several key discoveries in molecular biology and clinical cardiology and exemplifies the synergistic relationship between basic and clinical research. This article chronicles this journey from molecular biology to myocardial infarction.",
author = "Chien, {K. R.} and R. Meidell and R. Gerard",
year = "1987",
language = "English (US)",
volume = "293",
pages = "201--207",
journal = "The American journal of the medical sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Tissue plasminogen activator

T2 - From molecular biology to myocardial infarction

AU - Chien, K. R.

AU - Meidell, R.

AU - Gerard, R.

PY - 1987

Y1 - 1987

N2 - The recent development of recombinant tissue plasminogen activator as a therapeutic agent during acute myocardial infarction is one of the most lucid examples of the potential impact of recombinant DNA technology in clinical medicine. This remarkable achievement would not have been possible without several key discoveries in molecular biology and clinical cardiology and exemplifies the synergistic relationship between basic and clinical research. This article chronicles this journey from molecular biology to myocardial infarction.

AB - The recent development of recombinant tissue plasminogen activator as a therapeutic agent during acute myocardial infarction is one of the most lucid examples of the potential impact of recombinant DNA technology in clinical medicine. This remarkable achievement would not have been possible without several key discoveries in molecular biology and clinical cardiology and exemplifies the synergistic relationship between basic and clinical research. This article chronicles this journey from molecular biology to myocardial infarction.

UR - http://www.scopus.com/inward/record.url?scp=0023187643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023187643&partnerID=8YFLogxK

M3 - Article

C2 - 3105313

AN - SCOPUS:0023187643

VL - 293

SP - 201

EP - 207

JO - The American journal of the medical sciences

JF - The American journal of the medical sciences

SN - 0002-9629

IS - 3

ER -